Leaflet MUCOSOLVAN 15mg chewing gum

Product code:
W68461001
Quantity:
20
Indicated for:
respiratory disorders with viscous secretions
Route of administration:
oromucosal
Substance:
ambroxol (mucolytic)
ATC
R05CB06 — Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Ambroxol is a mucolytic agent used to treat respiratory conditions characterized by excessive production of viscous mucus. It is indicated for acute and chronic bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and other lung conditions involving difficulty in mucus clearance.

Ambroxol works by reducing mucus viscosity and stimulating the activity of cilia in the airways, facilitating expectoration. It is effective in relieving productive cough and improving breathing.

Additionally, ambroxol has anti-inflammatory and antioxidant properties, making it useful in reducing airway inflammation. In some cases, it is also used to alleviate sore throat pain due to its local anesthetic effect.

It is available in the form of tablets, syrup, oral solution, or inhalation, and is well-tolerated by most patients. Side effects are rare and may include nausea, stomach discomfort, or mild allergic reactions.

General data about MUCOSOLVAN 15mg

Substance:
ambroxol
Date of latest medicines list:
01-04-2022
Product code:
W68461001
Concentration:
15mg
Pharmaceutical form:
chewing gum
Quantity:
20
Product type:
Original
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA
Holder:
OPELLA HEALTHCARE ROMANIA SRL - ROMANIA
Number:
9085/2016/01
Shelf life:
2 years

Concentrations available for ambroxol

  • 0.3%
  • 0.75%
  • 15mg
  • 15mg/5ml
  • 15mg/ml
  • 20mg
  • 30mg
  • 30mg/5ml
  • 3mg/ml
  • 50mg/g
  • 60mg
  • 6mg/ml
  • 7.5mg/ml
  • 75mg